Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
€ 7,56 ↑0.24 (3.28%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership241,463 shares
Ownership 0.36%
Fmr Llc ownership in KUR / Kura Oncology, Inc.

2022-03-10 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 241,463 shares of Kura Oncology, Inc. (DE:KUR). This represents 0.362 percent ownership of the company. In their previous filing dated 2022-01-10 , Fmr Llc had reported owning 5,582,200 shares, indicating a decrease of -95.67 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2022-03-10 2022-03-10 13G/A 5,582,200 241,463 -95.67 0.36 -95.68
2022-01-10 2022-01-10 13G/A 9,116,040 5,582,200 -38.77 8.39 -39.32
2021-02-08 2021-02-08 13G/A 6,797,202 9,116,040 34.11 13.82 -7.85
2020-02-07 2020-02-07 13G/A 4,870,878 6,797,202 39.55 15.00 38.43
2019-07-10 2019-07-10 13G/A 2,285,510 4,870,878 113.12 10.84 80.34
2019-02-13 2019-02-13 13G/A 3,366,419 2,285,510 -32.11 6.01 -34.22
2018-07-10 2018-07-10 13G/A 4,768,051 3,366,419 -29.40 9.13 -36.11
2018-02-12 2018-02-12 13G/A 2,081,171 4,768,051 129.10 14.30 107.58
2018-02-09 2018-02-09 13G/A 2,403,208 2,081,171 -13.40 6.89 -13.40
2017-12-11 2017-12-11 13G/A 2,815,919 2,403,208 -14.66 7.95 -39.65
2017-02-14 2017-02-14 13G/A 3,113,719 2,815,919 -9.56 13.18 -9.55
2016-02-12 2016-02-12 13G/A 1,846,519 3,113,719 68.63 14.57 14.48
2015-04-10 2015-04-10 13G 1,846,519 12.73

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM 50127T109 317,652 11,050 3.60 2,583 -18.93 0.0000
2026-02-17 2025-12-31 13F KURA ONCOLOGY COM 50127T109 306,602 219,728 252.93 3,186 314.71 0.0002
2025-11-13 2025-09-30 13F KURA ONCOLOGY COM 50127T109 86,874 41,673 92.19 769 195.38 0.0000
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM 50127T109 45,201 32,113 245.36 261 202.33 0.0000
2025-05-12 2025-03-31 13F KURA ONCOLOGY COM 50127T109 13,088 -171,340 -92.90 86 -94.65 0.0000
2025-02-13 2024-12-31 13F KURA ONCOLOGY COM 50127T109 184,428 97,997 113.38 1,606 -4.86 0.0001
2024-11-13 2024-09-30 13F KURA ONCOLOGY COM 50127T109 86,431 17,913 26.14 1,689 19.72 0.0001
2024-08-13 2024-06-30 13F KURA ONCOLOGY COM 50127T109 68,518 3,845 5.95 1,411 2.25 0.0001
2024-05-13 2024-03-31 13F KURA ONCOLOGY COM 50127T109 64,673 199 0.31 1,379 48.76 0.0001
2024-02-13 2023-12-31 13F KURA ONCOLOGY COM 50127T109 64,474 -6,005 -8.52 927 44.39 0.0001
2023-11-13 2023-09-30 13F KURA ONCOLOGY COM 50127T109 70,479 4,315 6.52 643 -8.29 0.0001
2023-08-11 2023-06-30 13F KURA ONCOLOGY COM 50127T109 66,164 25,325 62.01 700 40.28 0.0001
2023-08-11 2023-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 40,839 1,481 3.76 499 2.25 0.0000
2023-05-11 2023-03-31 13F KURA ONCOLOGY COM 50127T109 40,839 1,481 499 0.0000
2023-02-13 2022-12-31 13F KURA ONCOLOGY COM 50127T109 39,358 -27,465 -41.10 488 -46.55 0.0000
2022-11-10 2022-09-30 13F KURA ONCOLOGY COM 50127T109 66,823 553 0.83 913 -24.79 0.0001
2022-08-12 2022-06-30 13F KURA ONCOLOGY COM 50127T109 66,270 -278 -0.42 1,214 13.46 0.0001
2022-05-13 2022-03-31 13F KURA ONCOLOGY COM 50127T109 66,548 -5,515,652 -98.81 1,070 -98.63 0.0001
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 5,582,200 -642,573 -10.32 78,151 -32.97 0.0058
2022-02-14 2021-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 6,224,773 -1,579,202 -20.24 116,589 -28.35 0.0092
2021-11-15 2021-09-30 13F KURA ONCOLOGY COM 50127T109 6,224,773 -1,579,202 116,589 0.0092
2021-08-13 2021-06-30 13F KURA ONCOLOGY COM 50127T109 7,803,975 -1,375,494 -14.98 162,713 -37.30 0.0127
2021-05-14 2021-03-31 13F KURA ONCOLOGY COM 50127T109 9,179,469 63,429 0.70 259,503 -12.84 0.0222
2021-02-08 2020-12-31 13F KURA ONCOLOGY COM 50127T109 9,116,040 1,876,852 25.93 297,730 34.23 0.0265
2020-11-13 2020-09-30 13F KURA ONCOLOGY COM 50127T109 7,239,188 -845,495 -10.46 221,809 68.32 0.0224
2020-08-24 2020-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 8,084,683 1,270,477 18.64 131,780 94.36 0.0145
2020-08-13 2020-06-30 13F KURA ONCOLOGY COM 50127T109 8,084,683 1,270,477 131,780 3,237.4490
2020-05-14 2020-03-31 13F KURA ONCOLOGY COM 50127T109 6,814,206 17,004 0.25 67,801 -27.46 0.0094
2020-02-07 2019-12-31 13F KURA ONCOLOGY COM 50127T109 6,797,202 64,213 0.95 93,462 -8.50 0.0103
2019-11-13 2019-09-30 13F KURA ONCOLOGY COM 50127T109 6,732,989 1,862,111 38.23 102,139 6.50 0.0123
2019-08-13 2019-06-30 13F KURA ONCOLOGY COM 50127T109 4,870,878 3,024,868 163.86 95,908 213.17 0.0112
2019-05-13 2019-03-31 13F KURA ONCOLOGY COM 50127T109 1,846,010 -439,500 -19.23 30,625 -4.56 0.0037
2019-02-13 2018-12-31 13F KURA ONCOLOGY COM 50127T109 2,285,510 0 0.00 32,089 -19.77 0.0044
2018-11-09 2018-09-30 13F KURA ONCOLOGY COM 50127T109 2,285,510 -1,080,909 -32.11 39,996 -34.72 0.0045
2018-08-10 2018-06-30 13F KURA ONCOLOGY COM 50127T109 3,366,419 -1,067,096 -24.07 61,269 -26.30 0.0072
2018-05-14 2018-03-31 13F KURA ONCOLOGY COM 50127T109 4,433,515 2,352,344 113.03 83,128 161.06 0.0099
2018-02-12 2017-12-31 13F KURA ONCOLOGY COM 50127T109 2,081,171 -505,748 -19.55 31,842 -17.67 0.0037
2017-11-13 2017-09-30 13F KURA ONCOLOGY COM 50127T109 2,586,919 -229,000 -8.13 38,674 47.68 0.0047
2017-08-29 2017-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 2,815,919 0 0.00 26,188 5.68 0.0033
2017-08-11 2017-06-30 13F KURA ONCOLOGY COM 50127T109 2,815,919 0 26,188
2017-05-11 2017-03-31 13F KURA ONCOLOGY COM 50127T109 2,815,919 0 0.00 24,780 49.15 0.0031
2017-02-10 2016-12-31 13F KURA ONCOLOGY COM 50127T109 2,815,919 0 0.00 16,614 -5.60 0.0022
2016-11-14 2016-09-30 13F KURA ONCOLOGY COM 50127T109 2,815,919 0 0.00 17,599 130.63 0.0023
2016-08-11 2016-06-30 13F KURA ONCOLOGY COM 50127T109 2,815,919 -281,435 -9.09 7,631 -39.17 0.0010
2016-05-16 2016-03-31 13F KURA ONCOLOGY COM 50127T109 3,097,354 -16,365 -0.53 12,544 -52.04 0.0017
2016-02-12 2015-12-31 13F KURA ONCOLOGY COM 50127T109 3,113,719 3,113,719 26,155 0.0035
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.